Irish Examiner on MSN

Are you in a co-dependent relationship?

In Elizabeth Gilbert's new memoir, she recounts how her co-dependency drove her to such despair that she planned to murder ...
Psychology Today

6 Ways Trauma Shows Up in Your Parenting Every Single Day

Why do you explode over tiny things while other parents stay calm? The answer may lie in how unprocessed trauma creates ...
The Manila Times

Best Fat Burner for Men- Effective Men’s Fat Burning Supplements- Wolfsan Brand launch 2025

In 2025, Wolfson Brands has unveiled an advanced line of Best fat-burning supplements for man designed to align with the ...

Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine

Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine Detailed results from completed Phase 1b/2a trial of ACI-35.030 and JACI-35.054 ...
The Manila Times

PhenQ Australia Over the Counter | Fast Acting Fat Burner and Appetite Suppressant Australian Launch OTC by PhenQ

Widely regarded as arguably the best OTC fat burner and appetite suppressant pill, PhenQ helps users tackle fat loss from ...

GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update

Cash and cash equivalents totaled €107.5 million as of June 30, 2025, excluding the €26.5 million milestone invoiced in May 2025 (received in ...
eLife

Adrenomedullin restores the human cortical interneurons migration defects induced by hypoxia

In this manuscript, the authors investigate the migration of human cortical interneurons under hypoxic conditions using forebrain assembloids and developing human brain tissue, and probe the ...

Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III

IPN10200 is a recombinant, first-in-class molecule uniquely engineered to generate increased receptor affinity and internalization that produces ...

Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC

Bylvay® is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated ...

Ipsen Pharma: Bylvay (odevixibat) approved in Japan for rare liver disease PFIC

Bylvay® is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated with progressive familial intrahepatic cholestasis (PFIC) in Japan, offering a ...